Dupuytren's disease - results of the RIDD trial

In what could be a breakthrough for patients with Dupuytren's disease, the RIDD trial showed that Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

[@cOoO0o0OoO0Oo0OoO0o]

Awesome! What a relief for so many of us

[@oskar5594]

Lets go brandon!

[@22fordfx49]

Great news and new hope for dupuytrens patients!

[@thehmc]

Game changer.

[@Havana1975xx]

Congratulations to ATNF shareholders looks like great times are coming!

[@wstagner]

how right you are, felipe!

[@wstagner]

who wants to go thru 3 treatments? not to mention the price of this drug is more expensive than Xiaflex! have needle aponeurotomy. it takes 20 minutes and you walk out of the docs office with straight fingers. This is only a breakthru for the drug company that developed adalimum. and another thing, who makes up these names?

[@georgemarchionda7335]

When will this be made available in Canada and US ?

[@e3a3c3]

I read the article, and was not impressed. There are many studies in the literature showing similar results with steroid injection of nodules, and I have personal experience that confirms it (3 years with softening and shrinkage of nodules.) What is not similar is the price: last time I checked, adalimumab was $7000 a vial. Kenalog and other steroids are cheap cheap cheap.

[@azr1453]

What were the steroid injections you were having if you don’t mind me asking.

[@e3a3c3]

Triamcinolone (Kenalog) 40. Single session, 3 nodules injected, almost painless during and after. Google triamcinolone dupuytrens and read the articles.@@azr1453